This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2004 Nov 16;110(20):3281-8.

doi: 10.1161/01.CIR.0000147274.83071.68.

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

John J V McMurray¹, Marc A Pfeffer, Karl Swedberg, Victor J Dzau

Affiliations

PMID: 15545527
DOI: 10.1161/01.CIR.0000147274.83071.68

Review

Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?

John J V McMurray et al. Circulation. 2004.

. 2004 Nov 16;110(20):3281-8.

doi: 10.1161/01.CIR.0000147274.83071.68.

Authors

John J V McMurray¹, Marc A Pfeffer, Karl Swedberg, Victor J Dzau

Affiliation

¹ Department of Cardiology, Western Infirmary, Glasgow, Scotland, G12 8QQ, UK. j.mcmurray@bio.gla.ac.uk

PMID: 15545527
DOI: 10.1161/01.CIR.0000147274.83071.68

No abstract available

PubMed Disclaimer

Similar articles

Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
[No authors listed] [No authors listed] Prescrire Int. 2005 Oct;14(79):180-6. Prescrire Int. 2005. PMID: 16285075
Combining neuroendocrine inhibitors in heart failure: reflections on safety and efficacy.
Jneid H, Moukarbel GV, Dawson B, Hajjar RJ, Francis GS. Jneid H, et al. Am J Med. 2007 Dec;120(12):1090.e1-8. doi: 10.1016/j.amjmed.2007.02.029. Am J Med. 2007. PMID: 18060931 Review.
Inhibiting the renin-angiotensin system in myocardial infarction and heart failure: lessons from SAVE, VALIANT and CHARM, and other clinical trials.
Tokmakova M, Solomon SD. Tokmakova M, et al. Curr Opin Cardiol. 2006 Jul;21(4):268-72. doi: 10.1097/01.hco.0000231394.79609.24. Curr Opin Cardiol. 2006. PMID: 16755193 Review.
Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
Azizi M, Ménard J. Azizi M, et al. Circulation. 2004 Jun 1;109(21):2492-9. doi: 10.1161/01.CIR.0000131449.94713.AD. Circulation. 2004. PMID: 15173039 Review. No abstract available.
Pharmacotherapy for heart failure with left ventricular dysfunction: beyond angiotensin-converting enzyme inhibitors and beta-blockers.
Norgard NB, Stark JE. Norgard NB, et al. Pharmacotherapy. 2008 Jul;28(7):920-31. doi: 10.1592/phco.28.7.920. Pharmacotherapy. 2008. PMID: 18576907 Review.

See all similar articles

Cited by

Pediatric Chronic Heart Failure: Age-Specific Considerations of Medical Therapy.
Koubský K. Koubský K. Physiol Res. 2024 Nov 29;73(S2):S597-S613. doi: 10.33549/physiolres.935438. Physiol Res. 2024. PMID: 39589305 Free PMC article. Review.
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
Dincer UD. Dincer UD. Diabetes Metab Syndr Obes. 2012;5:89-99. doi: 10.2147/DMSO.S30005. Epub 2012 Apr 5. Diabetes Metab Syndr Obes. 2012. PMID: 22563249 Free PMC article.
Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction.
Bissessor N, White H. Bissessor N, et al. Vasc Health Risk Manag. 2007;3(4):425-30. Vasc Health Risk Manag. 2007. PMID: 17969373 Free PMC article. Review.
Macrophage-produced VEGFC is induced by efferocytosis to ameliorate cardiac injury and inflammation.
Glinton KE, Ma W, Lantz C, Grigoryeva LS, DeBerge M, Liu X, Febbraio M, Kahn M, Oliver G, Thorp EB. Glinton KE, et al. J Clin Invest. 2022 May 2;132(9):e140685. doi: 10.1172/JCI140685. J Clin Invest. 2022. PMID: 35271504 Free PMC article.
The natriuretic peptides system in the pathophysiology of heart failure: from molecular basis to treatment.
Volpe M, Carnovali M, Mastromarino V. Volpe M, et al. Clin Sci (Lond). 2016 Jan;130(2):57-77. doi: 10.1042/CS20150469. Clin Sci (Lond). 2016. PMID: 26637405 Free PMC article. Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Substances

Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information